Remdesivir. You mean the drug that went through testing. Had listed side effects but showed clinical significance? That received it's EUA because it was first across the finish line when there were no other drugs available?
The very same Remdesivir that also set the low bar for other drugs to receive their EUAs. The bar so low you have to trip on it to fail, and yet CYDY broke it's neck on that low bar?
News 
Market Data 
Discover 
